PHARMACOKINETICS OF AMSACRINE IN PATIENTS RECEIVING COMBINED CHEMOTHERAPY FOR TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA

被引：19

作者：

JURLINA, JL

VARCOE, AR

PAXTON, JW

机构：

[1] UNIV AUCKLAND,SCH MED,DEPT PHARMACOL & CLIN PHARMACOL,AUCKLAND,NEW ZEALAND

[2] AUCKLAND HOSP,DEPT HAEMATOL,AUCKLAND,NEW ZEALAND

来源：

CANCER CHEMOTHERAPY AND PHARMACOLOGY | 1985年 / 14卷 / 01期

关键词：

D O I：

10.1007/BF00552719

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：21 / 25

页数：5

共 26 条

[1]

ARLIN ZA, 1981, CANCER CLIN TRIALS, V4, P317

[2]

ARLIN ZA, 1983, AMSACRINE CURRENT PE, P977

[3] POTENTIAL ANTITUMOR AGENTS .12. 9-ANILINOACRIDINES [J].

ATWELL, GJ ;

CAIN, BF ;

SEELYE, RN .

JOURNAL OF MEDICINAL CHEMISTRY, 1972, 15 (06) :611-&

[4] POTENTIAL ANTITUMOR AGENTS .14. ACRIDYLMETHANESULFONANILIDES [J].

CAIN, BF ;

SEELYE, RN ;

ATWELL, GJ .

JOURNAL OF MEDICINAL CHEMISTRY, 1974, 17 (09) :922-930

[5] EXPERIMENTAL ANTITUMOR PROPERTIES OF 3 CONGENERS OF ACRIDYLMETHANESULFONANILIDE (AMSA) SERIES [J].

CAIN, BF ;

ATWELL, GJ .

EUROPEAN JOURNAL OF CANCER, 1974, 10 (08) :539-549

[6]

CYSYK RL, 1971, DRUG METAB DISPOS, V5, P579

[7]

GIBALDI M, 1975, PHARMACOKINETICS, P69

[8] PHASE-I AND PHASE-2 STUDY OF AMSA IN CHILDHOOD TUMORS [J].

GOLDMAN, A ;

MALPAS, JS .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1982, 9 (01) :53-56

[9]

HALL SW, 1983, CANCER RES, V43, P3422

[10]

JACQUILLAT C, 1983, AMSACRINE CURRENT PE, P41

← 1 2 3 →